Kymera Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of KYMR for the last quarter is 10.29 M USD, and it's 78.52% lower compared to the previous quarter. The net income of Q1 24 is -48.56 M USD.